首页> 外文期刊>Clinical Medicine Insights: Pathology >Reappraisal of the Etiology of Extracorpuscular Non-Autoimmune Acquired Hemolytic Anemia in 2657 Hospitalized Patients with Non-Neoplastic Disease
【24h】

Reappraisal of the Etiology of Extracorpuscular Non-Autoimmune Acquired Hemolytic Anemia in 2657 Hospitalized Patients with Non-Neoplastic Disease

机译:对2657例住院的非赘生性疾病患者进行体外非自身免疫性获得性溶血性贫血病因的重新评估

获取原文
       

摘要

Introduction: Unlike autoimmune hemolytic anemia (AIHA), literature on the etiological study of non-autoimmune hemolytic anemia (non-AIHA) is scarce. The incidence and prevalence of non-AIHA in different geographic regions are largely unknown perhaps owing to the lack of perspective investigation and different profiles of etiologies from different geographic regions. We aimed to examine the real-world etiology or mechanisms of the non-hereditary non-AIHA from a nationwide population-based administrative claim database in Taiwan.Patients and methods: The National Health Insurance Research Database of Taiwan was adopted for this research. The studied population was total inpatient claim records including both pediatric and adult patients, contributed by a population of 23 million insured individuals in Taiwan. From 2002 to 2008, we retrieved 3,903 patients having no pre-existing malignancy discharged after inpatient management for acquired hemolytic anemia, which was defined as coding in discharge diagnoses containing ICD-9-CM code 283. By contrast, ICD-9-CM code 282 and all of the sub-codes are for hereditary hemolytic anemias.Results: AIHA accounted for 32% of the total cases. Among 2,657 patients with non-AIHA, mechanical or microangiopathic mechanism accounted for 19% of cases; hemolytic-uremic syndrome (HUS) 4%, hemoglobinuria because of hemolysis from external causes such as paroxysmal nocturnal hemoglobinuria (PNH) and march hemoglobinuria 7%, and chronic idiopathic hemolytic anemia or other unspecified non-AIHA 69%. We looked further for specific etiology or mechanism for this group of patients with non-hereditary extrinsic non-AIHA (n = 2,657). The explanatory disease states or conditions were splenomegaly; alcohol use disorder (spur cell hemolysis); heart-valve prosthesis; malignant hypertension; disseminated intravascular coagulation; transfusion reaction; dengue fever-induced hemolytic anemia; direct parasitization; snake, lizard, or spider bite; and Wilson’s disease with internal toxin mechanism. All these cases can explain up to 34.6% of all the non-hereditary extrinsic non-AIHA cases. Fragmentation hemolysis (HUS, heart-valve prosthesis, malignant hypertension, and disseminated intravascular coagulation) accounted for 7.4% of non-AIHA hospitalized patients with non-neoplastic disease.Conclusions: This article is the first one to clearly demonstrate that the non-neoplastic-induced HUS requiring hospitalization cases in Taiwan, which has a population of over 23 million were 110 over a span of seven years, 16 cases per year. Although the etiologies of non-AIHA are well known and described in the literature, this work added the statistical percentages of the various etiologies of non-AIHA in Taiwan.
机译:简介:与自身免疫性溶血性贫血(AIHA)不同,关于非自身免疫性溶血性贫血(non-AIHA)病因学研究的文献很少。非AIHA在不同地理区域的发病率和患病率在很大程度上是未知的,这也许是由于缺乏观点调查和来自不同地理区域的病因资料不同所致。我们旨在从台湾全国基于人口的行政索赔数据库中研究非遗传性非AIHA的现实病因或机制。患者与方法:本研究采用台湾国家健康保险研究数据库。研究的人群是包括2300万台湾被保险人在内的总住院索赔记录,包括小儿和成年患者。从2002年到2008年,我们检索了3,903名因获得性溶血性贫血在住院治疗后未曾存在过恶性肿瘤的患者,其定义为出院诊断中包含ICD-9-CM代码283的编码。相比之下,ICD-9-CM代码282和所有子代码均用于遗传性溶血性贫血。结果:AIHA占总病例的32%。在2657例非AIHA患者中,机械或微血管病变机制占19%。溶血性尿毒症综合征(HUS)为4%,血红蛋白尿是由于外部原因引起的溶血,如阵发性夜间血红蛋白尿(PNH)和行军血红蛋白尿7%,以及慢性特发性溶血性贫血或其他未指定的非AIHA占69%。我们进一步寻找了这组非遗传性非AIHA(n = 2657)患者的具体病因或机制。解释性疾病状态或状况为脾肿大;饮酒障碍(干细胞溶血);心脏瓣膜假体恶性高血压;弥散性血管内凝血;输血反应登革热引起的溶血性贫血;直接寄生;蛇,蜥蜴或蜘蛛咬;以及具有内部毒素机制的威尔逊氏病。所有这些病例最多可以解释所有非遗传性非AIHA病例的34.6%。破碎性溶血(HUS,心脏瓣膜假体,恶性高血压和弥散性血管内凝血)占非AIHA住院非肿瘤性疾病患者的7.4%。结论:本文是第一个明确证明非肿瘤性疾病的患者人口超过2300万的台湾,由于HUS导致需要住院的病例,在7年的时间里有110例,每年16例。尽管非AIHA的病因众所周知并在文献中有所描述,但这项​​工作增加了台湾非AIHA的各种病因的统计百分比。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号